{"entity":{"type":"insider","cik":"0001479797","url":"/insider/0001479797","json_url":"/insider/0001479797.json","name":"MD Sass Finstrat Arcadia Capital Holdings, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2010-01-08","last":"2011-04-21","span_basis":"filed_date"},"name_variants":[{"name":"MD Sass Finstrat Arcadia Capital Holdings, LLC","source":"filing","n_filings":5,"first_seen":"2010-01-08","last_seen":"2011-04-21"}],"transactions":[{"id":8940030,"accession":"0001181431-11-025047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-025047","line_url":"/filing/0001181431-11-025047#line-1","is_derivative":false,"issuer_cik":"0000821536","issuer_name":"HEARUSA INC","issuer_ticker":"EAR","issuer_name_source":null,"issuer_url":"/issuer/0000821536","owner_cik":null,"owner_name":"Arcadia Opportunity Master Fund, LTD; MD Sass Finstrat Arcadia Capital Holdings, LLC; Arcadia Capital Advisors, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":8050.0,"total_display":"8,050.00","shares_owned_after":4499874.0,"shares_owned_after_display":"4,499,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-20","filed_date":"2011-04-21","scope":"insider"},{"id":7537319,"accession":"0001144204-10-008501","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-10-008501","line_url":"/filing/0001144204-10-008501#line-5","is_derivative":false,"issuer_cik":"0001418919","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001418919","owner_cik":null,"owner_name":"MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S; Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50109.0,"shares_display":"50,109","price_per_share":15.739,"price_display":"15.74","price_state":"stated","total_value":788665.551,"total_display":"788,665.55","shares_owned_after":154158.0,"shares_owned_after_display":"154,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-16","filed_date":"2010-02-16","scope":"insider"},{"id":7537317,"accession":"0001144204-10-008501","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-10-008501","line_url":"/filing/0001144204-10-008501#line-4","is_derivative":false,"issuer_cik":"0001418919","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001418919","owner_cik":null,"owner_name":"MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S; Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2820.0,"shares_display":"2,820","price_per_share":16.0681,"price_display":"16.07","price_state":"stated","total_value":45312.042,"total_display":"45,312.04","shares_owned_after":204267.0,"shares_owned_after_display":"204,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-12","filed_date":"2010-02-16","scope":"insider"},{"id":7537315,"accession":"0001144204-10-008501","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-10-008501","line_url":"/filing/0001144204-10-008501#line-3","is_derivative":false,"issuer_cik":"0001418919","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001418919","owner_cik":null,"owner_name":"MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S; Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2071.0,"shares_display":"2,071","price_per_share":16.1873,"price_display":"16.19","price_state":"stated","total_value":33523.8983,"total_display":"33,523.90","shares_owned_after":207087.0,"shares_owned_after_display":"207,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-11","filed_date":"2010-02-16","scope":"insider"},{"id":7537313,"accession":"0001144204-10-008501","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-10-008501","line_url":"/filing/0001144204-10-008501#line-2","is_derivative":false,"issuer_cik":"0001418919","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001418919","owner_cik":null,"owner_name":"MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S; Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":16.0175,"price_display":"16.02","price_state":"stated","total_value":8008.75,"total_display":"8,008.75","shares_owned_after":209158.0,"shares_owned_after_display":"209,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-11","filed_date":"2010-02-16","scope":"insider"},{"id":7537308,"accession":"0001144204-10-008501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-10-008501","line_url":"/filing/0001144204-10-008501#line-1","is_derivative":false,"issuer_cik":"0001418919","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001418919","owner_cik":null,"owner_name":"MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S; Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":15.98,"price_display":"15.98","price_state":"stated","total_value":7990.0,"total_display":"7,990.00","shares_owned_after":209658.0,"shares_owned_after_display":"209,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-11","filed_date":"2010-02-16","scope":"insider"},{"id":7399541,"accession":"0001019056-10-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019056-10-000036","line_url":"/filing/0001019056-10-000036#line-1","is_derivative":false,"issuer_cik":"0001418919","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001418919","owner_cik":null,"owner_name":"Frank James S; Rofe Richard S; MD Sass Finstrat Arcadia Capital Holdings, LLC; Arcadia Opportunity Master Fund, LTD; Arcadia Capital Advisors, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1903.0,"shares_display":"1,903","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":26642.0,"total_display":"26,642.00","shares_owned_after":99367.0,"shares_owned_after_display":"99,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-12","filed_date":"2010-01-15","scope":"insider"},{"id":7542109,"accession":"0001019056-10-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019056-10-000019","line_url":"/filing/0001019056-10-000019#line-1","is_derivative":false,"issuer_cik":"0001418919","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001418919","owner_cik":null,"owner_name":"Frank James S; Arcadia Capital Advisors, LLC; Rofe Richard S; MD Sass Finstrat Arcadia Capital Holdings, LLC; Arcadia Opportunity Master Fund, LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5107.0,"shares_display":"5,107","price_per_share":11.25,"price_display":"11.25","price_state":"stated","total_value":57453.75,"total_display":"57,453.75","shares_owned_after":97464.0,"shares_owned_after_display":"97,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-31","filed_date":"2010-01-08","scope":"insider"},{"id":9216156,"accession":"0001019056-10-000018","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001019056-10-000018","line_url":"/filing/0001019056-10-000018#line-4","is_derivative":false,"issuer_cik":"0001475843","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001475843","owner_cik":null,"owner_name":"Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S; MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1100.0,"total_display":"1,100.00","shares_owned_after":210158.0,"shares_owned_after_display":"210,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-30","filed_date":"2010-01-08","scope":"insider"},{"id":9216153,"accession":"0001019056-10-000018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001019056-10-000018","line_url":"/filing/0001019056-10-000018#line-3","is_derivative":false,"issuer_cik":"0001475843","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001475843","owner_cik":null,"owner_name":"Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S; MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58.0,"shares_display":"58","price_per_share":11.09,"price_display":"11.09","price_state":"stated","total_value":643.22,"total_display":"643.22","shares_owned_after":210058.0,"shares_owned_after_display":"210,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-30","filed_date":"2010-01-08","scope":"insider"},{"id":9216154,"accession":"0001019056-10-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001019056-10-000018","line_url":"/filing/0001019056-10-000018#line-2","is_derivative":false,"issuer_cik":"0001475843","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001475843","owner_cik":null,"owner_name":"Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S; MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5700.0,"shares_display":"5,700","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":62700.0,"total_display":"62,700.00","shares_owned_after":92357.0,"shares_owned_after_display":"92,357","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-29","filed_date":"2010-01-08","scope":"insider"},{"id":9216155,"accession":"0001019056-10-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019056-10-000018","line_url":"/filing/0001019056-10-000018#line-1","is_derivative":false,"issuer_cik":"0001475843","issuer_name":"CPEX Pharmaceuticals, Inc.","issuer_ticker":"CPEX","issuer_name_source":null,"issuer_url":"/issuer/0001475843","owner_cik":null,"owner_name":"Arcadia Capital Advisors, LLC; Arcadia Opportunity Master Fund, LTD; Frank James S; MD Sass Finstrat Arcadia Capital Holdings, LLC; Rofe Richard S","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20657.0,"shares_display":"20,657","price_per_share":10.85,"price_display":"10.85","price_state":"stated","total_value":224128.45,"total_display":"224,128.45","shares_owned_after":86657.0,"shares_owned_after_display":"86,657","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-28","filed_date":"2010-01-08","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000821536","name":"HEARUSA INC","url":"/issuer/0000821536","role":"Ten percent owner","n_filings":1,"first_seen":"2011-04-21","last_seen":"2011-04-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001418919","name":"CPEX Pharmaceuticals, Inc.","url":"/issuer/0001418919","role":"Ten percent owner","n_filings":4,"first_seen":"2010-01-08","last_seen":"2010-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001479797","retrieved_at":"2026-08-21T09:02:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}